24
Participants
Start Date
May 1, 2015
Primary Completion Date
September 1, 2019
Study Completion Date
September 1, 2019
Placebo
Placebo will consist of USP-grade or equivalent 0.9% Sodium Chloride for Injection. Doses of placebo will be drawn into labeled syringes by an independent, unblinded pharmacist or designee.
GI-6301 Vaccine (Yeast- Brachyury)
GI-6301 Vaccine is a heat-killed, recombinant yeast-based vaccine engineered to express the transcription factor, Brachyury. The Brachyury gene is used to transfect the parental yeast strain (S. cerevisiae W303 - a haploid strain with known mutations from wildtype yeast) to produce the final recombinant vaccine product.
Radiotherapy
Standard of care
wGT3X-BT Actigraph
wGT3X-BT is small, non-invasive, portable watch accelerometer worn on the subject's wrist for Cycle 1 through Cycle 9
NIH Clinical Center, Bethesda
Lead Sponsor
National Cancer Institute (NCI)
NIH
NantCell, Inc.
INDUSTRY